Published findings on breast cancer risk associated with different types of menopausal hormone therapy (MHT) are inconsistent, with limited information on long-term effects. This report brings together the epidemiological evidence, published and unpublished, on these associations, and reviews the relevant randomised evidence.
Resources
We do not endorse, approve, certify, or control any linked websites, their sponsors, or any of their policies, activities, products, or services. We do not assume responsibility for the accuracy, completeness, or timeliness of the information.
Visitors to any linked websites should not use or rely on the information contained therein.
Please click “Continue” to leave this website and proceed to the selected site.